Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / GENOMIC REV ETF
-
Number of holders
-
46
-
Total 13F shares, excl. options
-
1,154,665
-
Shares change
-
+382,868
-
Total reported value, excl. options
-
$33,528,825
-
Value change
-
+$11,399,069
-
Number of buys
-
31
-
Number of sells
-
-13
-
Price
-
$29.06
Significant Holders of ARK ETF TR - GENOMIC REV ETF (ARKG) as of Q2 2018
54 filings reported holding ARKG - ARK ETF TR - GENOMIC REV ETF as of Q2 2018.
ARK ETF TR - GENOMIC REV ETF (ARKG) has 46 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,154,665 shares
.
Largest 10 shareholders include MORGAN STANLEY (382,243 shares), UBS Group AG (146,292 shares), JANE STREET GROUP, LLC (93,178 shares), LPL Financial LLC (78,489 shares), Edelman Financial Services, LLC (75,326 shares), Cambridge Investment Research Advisors, Inc. (53,561 shares), Carroll Financial Associates, Inc. (37,062 shares), CITADEL ADVISORS LLC (34,445 shares), HighTower Advisors, LLC (29,496 shares), and COMMONWEALTH EQUITY SERVICES, LLC (25,561 shares).
This table shows the top 46 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.